HPV Testing Market Will Gigantic at 8.3% CAGR to Reach 1090 Million US$ by the End of 2025
The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.
View full press release